Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marsh & Mclennan Companies (MRSH) Cash & Equivalents (2016 - 2025)

Marsh & Mclennan Companies (MRSH) has disclosed Cash & Equivalents for 17 consecutive years, with $2.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 12.05% year-over-year to $2.7 billion, compared with a TTM value of $2.7 billion through Dec 2025, up 12.05%, and an annual FY2025 reading of $2.7 billion, up 12.05% over the prior year.
  • Cash & Equivalents was $2.7 billion for Q4 2025 at Marsh & Mclennan Companies, up from $2.5 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $11.6 billion in Q2 2023 and bottomed at $772.0 million in Q1 2022.
  • Average Cash & Equivalents over 5 years is $2.7 billion, with a median of $1.6 billion recorded in 2025.
  • The sharpest move saw Cash & Equivalents soared 1172.17% in 2023, then tumbled 85.41% in 2025.
  • Year by year, Cash & Equivalents stood at $1.8 billion in 2021, then fell by 17.69% to $1.4 billion in 2022, then soared by 132.87% to $3.4 billion in 2023, then fell by 28.59% to $2.4 billion in 2024, then rose by 12.05% to $2.7 billion in 2025.
  • Business Quant data shows Cash & Equivalents for MRSH at $2.7 billion in Q4 2025, $2.5 billion in Q3 2025, and $1.7 billion in Q2 2025.